Bausch Health Companies Company Description

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products.

The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products.

The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products.

The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018.

Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch Health Companies Inc.

Country	Canada
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	20,700
CEO	Thomas Appio

Contact Details

Address: 2150 St. ElzEar Boulevard West Laval, British Columbia H7L 4A8 Canada
Phone	514 744 6792
Website	bauschhealth.com

Stock Details

Ticker Symbol	BHC
Exchange	Toronto Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CA0717341071
SIC Code	2834

Key Executives

Name	Position
Thomas J. Appio	Chief Executive Officer and Director
Dr. Jonathan Sadeh M.D., M.Sc.	Executive Vice President, Chief Medical Officer and Head of Research & Development
William N. Woodfield	Senior Vice President and Treasurer